Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden : Clinical and molecular evaluation

1 Citations

Journal

  • Blood

    Blood 94 3325-3333, 1999

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570009750260018176
  • NII Article ID
    10015588016
  • Data Source
    • CiNii Articles

Report a problem

Back to top